Position in LLY
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$5,787,250
+$1,349,360 QoQ
Shares Held
4,825
0.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
2.42%
of 13F equity value
Holder Rank
#1,598
of 4,605 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026SCHULHOFF & CO INC holds $28,075,111 across 8 Drug Manufacturers - General names. LLY ranks #3 (20.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
40,998 | $10,412,262 | |
| 2 | ABBV |
AbbVie Inc.
|
26,880 | $6,764,083 | |
| 3 | LLY |
ELI LILLY & Co
This page
|
4,825 | $5,787,250 | |
| 4 | MRK |
Merck & Co., Inc.
|
12,263 | $1,575,795 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
20,914 | $1,205,064 | |
| 6 | PFE |
Pfizer Inc
|
45,453 | $1,094,508 | |
| 7 | NVS |
Novartis AG
|
6,053 | $948,626 | |
| 8 | AMGN |
Amgen Inc
|
794 | $287,523 |
All Filings in LLY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,787,250 | 4,825 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $4,437,890 | 4,825 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $5,212,198 | 4,850 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $3,694,446 | 4,842 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $3,774,484 | 4,842 | Shares | Sole | 2025-07-30 | |
| 2025-03-31 | $3,999,056 | 4,842 | Shares | Sole | 2025-05-07 | |
| 2024-12-31 | $3,738,024 | 4,842 | Shares | Sole | 2025-02-05 | |
| 2024-09-30 | $4,305,668 | 4,860 | Shares | Sole | 2024-11-06 | |
| 2024-06-30 | $4,418,254 | 4,880 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $3,796,444 | 4,880 | Shares | Sole | 2024-05-01 | |
| 2023-12-31 | $2,961,233 | 5,080 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | $2,744,734 | 5,110 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $2,426,971 | 5,175 | Shares | Sole | 2023-08-01 | |
| 2023-03-31 | $1,777,198 | 5,175 | Shares | Sole | 2023-05-05 | |
| 2022-12-31 | $1,893,222 | 5,175 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $1,673,336 | 5,175 | Shares | Sole | 2022-11-08 | |
| 2022-06-30 | $1,677,890 | 5,175 | Shares | Sole | 2022-08-05 | |
| 2022-03-31 | $1,481,964 | 5,175 | Shares | Sole | 2022-05-09 | |
| 2021-12-31 | $1,429,438 | 5,175 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $1,195,683 | 5,175 | Shares | Sole | 2021-11-08 | |
| 2021-06-30 | $1,176,290 | 5,125 | Shares | Sole | 2021-08-03 | |
| 2021-03-31 | $981,739 | 5,255 | Shares | Sole | 2021-04-30 | |
| 2020-12-31 | $991,935 | 5,875 | Shares | Sole | 2021-02-08 | |
| 2020-09-30 | $943,627 | 6,375 | Shares | Sole | 2020-11-04 | |
| 2020-06-30 | $1,046,647 | 6,375 | Shares | Sole | 2020-07-29 | |
| 2020-03-31 | $915,552 | 6,600 | Shares | Sole | 2020-04-30 | |
| No filing history on record for this holder in this stock. | ||||||